S. Dhib-jalbut

发表

Defective NF-κB activation in virus-infected neuronal cells is restored by genetic complementation

D. Kalvakolanu, Tao Wu, Yu Fang, 2002, Journal of NeuroVirology.

Isolation of HTLV‐II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV‐I‐associated myelopathy/tropical spastic paraparesis

D. McFarlin, T. Lehky, S. Jacobson, 1993, Annals of neurology.

Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial

R. Elashoff, D. Arnold, N. Sicotte, 2016, The Lancet Neurology.

Brain health: time matters in multiple sclerosis.

Gavin Giovannoni, Maria Pia Sormani, Anthony Traboulsee, 2016, Multiple sclerosis and related disorders.

Acute Multiple Sclerosis Lesion: Conversion of Restricted Diffusion Due to Vasogenic Edema

K. Balashov, S. Dhib-jalbut, L. Aung, 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle

C. Bever, D. Trisler, S. Sahu, 2009, Journal of Neuroimmunology.

Effect of interferon beta-1a on B7.1 and B7.2 B-cell expression and its impact on T-cell proliferation

F. Dangond, S. Dhib-jalbut, Hui Huang, 2013, Journal of Neuroimmunology.

Measles virus-specific cellular immunity in patients with vaccine failure

McFarland, H. McFarland, D. Griffin, 1993, Journal of clinical microbiology.

IFN-beta gene transfer into the central nervous system using bone marrow cells as a delivery system.

S. Wilt, P. Fishman, S. Dhib-jalbut, 2002, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Brain-derived neurotrophic factor (BDNF) gene delivery into the CNS using bone marrow cells as vehicles in mice

D. Trisler, S. Dhib-jalbut, M. Eglitis, 2004, Neuroscience Letters.

Treatment with oral 3,4 diaminopyridine improves leg strength in multiple sclerosis patients

C. Bever, H. Panitch, O. Khan, 1996, Neurology.

Phase 1 trial of transforming growth factor beta 2 in chronic progressive MS

P. Calabresi, H. McFarland, M. Levin, 1998, Neurology.

Mechanisms of immunomodulation by glatiramer acetate

R. Martin, W. Zhou, B. Bielekova, 2000, Neurology.

Interferon β-lb reduces Interferon γ-induced antigen-presenting capacity of human glial and B cells

H. Panitch, Kenneth P. Johnson, S. Dhib-jalbut, 1995, Journal of Neuroimmunology.

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells.

H. Panitch, S. Dhib-jalbut, R. Milo, 1995, Journal of neuroimmunology.

Sustained clinical benefits of glatiramer acetate in relapsing multiple sclerosis patients observed for 6 years

G. Barger, S. Reingold, C. Bever, 2000, Multiple sclerosis.

Protective autoimmunity in the nervous system.

S. Dhib-jalbut, J. Graber, S. Dhib-Jalbut, 2009, Pharmacology & therapeutics.

Abstracts & Insights on Biomarkers From the 2011 European Meeting in Multiple Sclerosis CME

F. Lublin, R. Fox, S. Dhib-jalbut, 2011 .

Cytokine profiles in pediatric multiple sclerosis

L. Krupp, K. Balashov, S. Dhib-jalbut, 2016, Multiple Sclerosis and Demyelinating Disorders.

Direct evidence that interferon-beta mediates enhanced HLA-class I expression in measles virus-infected cells.

S. Dhib-jalbut, E. Cowan, S. Dhib-Jalbut, 1993, Journal of immunology.

Interleukin-1β decreases HLA class II expression on a glioblastoma multiforme cell line

S. Dhib-jalbut, E. Cowan, M. Pierce, 1991, Journal of Neuroimmunology.

IFN-b-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-b-1b Therapeutic Effects in Multiple Sclerosis

K. Wandinger, S. Dhib-jalbut, Man Chen, 2000 .

Surface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein

M. Senoh, S. Yadav, S. Dhib-jalbut, 2020, Microorganisms.

The effect of vesnarinone on TNFα production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis

R. Martin, B. Bielekova, S. Dhib-jalbut, 1999, Journal of Neuroimmunology.

Clinical response to glatiramer acetate correlates with modulation of IFN-γ and IL-4 expression in multiple sclerosis

S. Dhib-jalbut, K. Costello, M. Chen, 2007, Multiple sclerosis.

Overlapping and distinct mechanisms of action of multiple sclerosis therapies

S. Dhib-jalbut, D. Kimbrough, J. Graber, 2010, Clinical Neurology and Neurosurgery.

Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1.

P. Albert, D. McFarlin, C. Raine, 1991, Journal of immunology.

Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor

S. Dhib-jalbut, Man Chen, R. Valenzuela, 2003, Journal of the Neurological Sciences.

Plasmacytoid dendritic cells in multiple sclerosis: Chemokine and chemokine receptor modulation by interferon-beta

P. Fitzgerald-Bocarsly, K. Balashov, S. Dhib-jalbut, 2010, Journal of Neuroimmunology.

Differential effect of interleukin-1β on Ia expression in astrocytes and microglia

D. McFarlin, S. Dhib-jalbut, M. Smith, 1993, Journal of Neuroimmunology.

Human microglia activate lymphoproliferative responses to recall viral antigens

G. Bergey, S. Dhib-jalbut, H. Eisenberg, 1996, Journal of Neuroimmunology.

Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity

K. Bulsara, Daniel Chen, J. Imitola, 2022, The Journal of international medical research.

Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells

C. Kufta, H. McFarland, S. Dhib-jalbut, 1990, Journal of Neuroimmunology.

Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b+CD4+ T Cells in the CNS during Progressive EAE

S. Dhib-jalbut, Kouichi Ito, N. Ito, 2014, PloS one.

Stem cell based delivery of IFN-β reduces relapses in experimental autoimmune encephalomyelitis

Aditi Gupta, C. Bever, David Ford, 2008, Journal of Neuroimmunology.

Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy.

P. Calabresi, Li'na Hu, S. Dhib-jalbut, 2005, Archives of neurology.

Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study

S. Dhib-jalbut, Kouichi Ito, M. Rametta, 2013, Journal of Neuroimmunology.

Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis

S. Yadav, K. Balashov, S. Dhib-jalbut, 2022, Frontiers in Immunology.

Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosis

S. Yadav, S. Dhib-jalbut, Kouichi Ito, 2021, Multiple sclerosis journal - experimental, translational and clinical.

Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype

M. Zhan, Roland Martin, Kenneth P. Johnson, 2003, Journal of Neuroimmunology.

Effect of combined IFNb-1a and glatiramer acetate therapy on GA-specific T-cell responses in multiple sclerosis

H. Panitch, S. Dhib-jalbut, K. Costello, 2002, Multiple sclerosis.

Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6 years

R. Martin, S. Dhib-jalbut, K. Conway, 2002, Journal of the Neurological Sciences.

Neutralizing antibodies to interferon β-1a and interferon β-1b in MS patients are cross-reactive

O. Khan, S. Dhib-jalbut, 1998, Neurology.

The Combined Effect of Nursing Support and Adverse Event Mitigation on Adherence to Interferon Beta-1b Therapy in Early Multiple Sclerosis: The START Study.

S. Dhib-jalbut, C. Markowitz, Francis Boateng, 2012, International journal of MS care.

Measles virus polypeptide‐specific antibody profile in multiple sclerosis

D. McFarlin, S. Dhib-jalbut, E. Bradburn, 1990, Neurology.

Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis

D. McFarlin, H. McFarland, J. Sever, 1988, Journal of virology.

Biomarkers of interferon Beta therapy in multiple sclerosis.

S. Dhib-jalbut, J. Graber, 2014, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Mechanism of measles virus failure to activate NF-κB in neuronal cells

Yu Fang, Zan-Min Song, S. Dhib-jalbut, 2011, Journal of NeuroVirology.

Failure of measles virus to activate nuclear factor-kappa B in neuronal cells: implications on the immune response to viral infections in the central nervous system.

S. Dhib-jalbut, J. Xia, Y. Fang, 1999, Journal of immunology.

Delay in the absolute latency of auditory brainstem response (ABR) component P1 in acute inflammatory demyelinating disease.

G. Jacobson, S. Dhib-jalbut, E. Means, 1986, Scandinavian audiology.

Extracellular human T‐cell lymphotropic virus type I tax protein induces cytokine production in adult human microglial cells

G. Bergey, T. Yamabe, P. Hoffman, 1994, Annals of neurology.

Delivery of transgenically modified adult bone marrow cells to the rodent central nervous system

S. Dhib-jalbut, M. M. Mouradian, M. Mouradian, 2004, Expert opinion on biological therapy.

Mechanisms of interferon beta action in multiple sclerosis

S. Dhib-jalbut, S. Dhib-Jalbut, 1997, Multiple sclerosis.

Differential Induction of IL-12 by IFN-β and IFN-γ in Human Macrophages

S. Dhib-jalbut, Hong Jiang, S. Dhib-Jalbut, 1998 .

A novel population of CD4+CD56+ myelin-reactive T cells lyses target cells expressing CD56/neural cell adhesion molecule.

H. McFarland, R. Martin, M. Vergelli, 1996, Journal of immunology.

Human T‐cell lymphotropic virus type II–associated myelopathy: Clinical and immunologic profiles

H. McFarland, T. Lehky, S. Jacobson, 1996, Annals of neurology.

The choroid plexus and the paradox of interferons in the aging brain.

S. Dhib-jalbut, 2015, Cytokine.

Cytotoxic T cells in paramyxovirus infection of humans.

S. Jacobson, S. Dhib-jalbut, S. Dhib-Jalbut, 1994, Current topics in microbiology and immunology.

Serum interferon β-1a (Avonex) levels following intramuscular injection in relapsing-remitting MS patients

S. Dhib-jalbut, Omar Khan, 1998, Neurology.

Multiple sclerosis-linked and interferon-beta-regulated gene expression in plasmacytoid dendritic cells

S. Greenberg, A. Brooks, K. Balashov, 2012, Journal of Neuroimmunology.

Interferon-β mechanisms of action in multiple sclerosis

S. Dhib-jalbut, S. Marks, S. Dhib-Jalbut, 2010, Neurology.

Interferon‐β inhibits toll‐like receptor 9 processing in multiple sclerosis

H. Weiner, K. Balashov, S. Dhib-jalbut, 2010, Annals of neurology.

Impaired human leukocyte antigen–restricted measles virus–specific cytotoxic T‐cell response in subacute sclerosing panencephalitis

D. McFarlin, H. McFarland, S. Jacobson, 1989, Annals of neurology.

Measles virus-polypeptide specificity of the cytotoxic T-lymphocyte response in multiple sclerosis

D. McFarlin, H. McFarland, S. Dhib-jalbut, 1989, Journal of Neuroimmunology.

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

S. Dhib-jalbut, S. Dhib-Jalbut, 2002, Neurology.

IL-27: a potential biomarker for responders to glatiramer acetate therapy

S. Yadav, S. Dhib-jalbut, S. Boppana, 2017, Journal of Neuroimmunology.

Predictive cytokine biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

S. Buyske, K. Balashov, M. Kaufman, 2016, Journal of Neuroimmunology.

Further understanding of the immunopathology of multiple sclerosis: impact on future treatments

S. Dhib-jalbut, Vikram Bhise, S. Dhib-Jalbut, 2016, Expert review of clinical immunology.

HLA DR and DQ alleles and haplotypes associated with clinical response to glatiramer acetate in multiple sclerosis.

S. Buyske, M. Kaufman, S. Dhib-jalbut, 2013, Multiple sclerosis and related disorders.

Immunologic aspects of multiple sclerosis.

S. Dhib-jalbut, S. Boppana, Hui Huang, 2011, The Mount Sinai journal of medicine, New York.

Glatiramer acetate induces a Th2-biased response and crossreactivity with myelin basic protein in patients with MS

R. Martin, S. Dhib-jalbut, K. Costello, 2001, Multiple sclerosis.

Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood

S. Yadav, S. Dhib-jalbut, S. Boppana, 2017, Proceedings of the National Academy of Sciences.

Results of a randomized, double-blind, placebo-controlled, crossover trial

C. Bever, H. Panitch, O. Khan, 2012 .

Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis

S. Dhib-jalbut, S. Dhib-Jalbut, 2007, Neurology.

Multiple sclerosis: Possible immunological mechanisms☆

H. McFarland, S. Dhib-jalbut, S. Dhib-Jalbut, 1989, Clinical Immunology and Immunopathology.

Comparison of IFN-β inducible gene expression in primary-progressive and relapsing-remitting multiple sclerosis

K. Balashov, S. Dhib-jalbut, S. Boppana, 2013, Journal of Neuroimmunology.

Neutralizing Antibodies to Interferon β-1a (IFNβ-1a; Avonex™) and Interferon β-1b (IFN β-1b; Betaseron®) are Cross Reactive

O. Khan, S. Dhib-jalbut, 1998, Neurology.

THE EFFECT OF INTERFERON β-1b ON CYTOKINE-INDUCED ADHESION MOLECULE EXPRESSION

S. Dhib-jalbut, Hong Jiang, Gary J. Williams, 1997, Neurochemistry International.

The effect of interferon β-1b on lymphocyte-endothelial cell adhesion

S. Dhib-jalbut, Hong Jiang, Gary J. Williams, 1996, Journal of Neuroimmunology.

Insight into the mechanism of action of dimethyl fumarate in multiple sclerosis

S. Yadav, S. Dhib-jalbut, Kouichi Ito, 2019, Journal of Molecular Medicine.

Advances in the immunopathogenesis of multiple sclerosis.

S. Yadav, S. Dhib-jalbut, Kouichi Ito, 2015, Current opinion in neurology.

C URRENT OPINION Advances in the immunopathogenesis of multiple sclerosis

S. Yadav, S. Dhib-jalbut, Kouichi Ito, 2015 .

Cytokine-gene expression in measles-infected adult human glial cells

G. Bergey, T. Yamabe, P. Hoffman, 1994, Journal of Neuroimmunology.

IFN-β-1b Inhibits IL-12 Production in Peripheral Blood Mononuclear Cells in an IL-10-Dependent Mechanism: Relevance to IFN-β-1b Therapeutic Effects in Multiple Sclerosis1

Xin Wang, K. Wandinger, S. Dhib-jalbut, 2000, The Journal of Immunology.

Treatment of the neuroleptic malignant syndrome with bromocriptine.

D. Silbergeld, T. Brott, S. Dhib-jalbut, 1983, JAMA.

Are Periventricular Lesions Specific for Multiple Sclerosis?

M. Inglese, K. Balashov, S. Dhib-jalbut, 2013, Journal of neurology & neurophysiology.

Hematopoietic progenitors express myelin basic protein and ensheath axons in Shiverer brain

C. Bever, D. Trisler, B. Pessac, 2013, Journal of Neuroimmunology.

Binding of serum IgA of multiple myeloma to normal peripheral nerve

S. Dhib-jalbut, B. Liwnicz, S. Dhib-Jalbut, 1986, Acta neurologica Scandinavica.

Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response

H. Panitch, G. Francis, S. Dhib-jalbut, 2007, Journal of Neuroimmunology.

Fibrinolysis induced clinical improvement in a patient with multiple sclerosis exacerbation.

I. Rybinnik, K. Balashov, S. Dhib-jalbut, 2020, Multiple sclerosis and related disorders.

Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases

D. Arnold, T. Wyss-Coray, B. Trapp, 2006, Journal of Neuroimmunology.

Glatiramer acetate (Copaxone) therapy for multiple sclerosis.

S. Dhib-jalbut, S. Dhib-Jalbut, 2003, Pharmacology & therapeutics.

Hematopoietic progenitors express neural genes

C. Bever, D. Trisler, B. Pessac, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives

S. Dhib-jalbut, Vikram Bhise, S. Dhib-Jalbut, 2021, Neurotherapeutics.

Rapidly progressive subacute sclerosing panencephalitis: an ultrastructural and immunoperoxidase study.

S. Dhib-jalbut, B. Liwnicz, 1984, European neurology.

Human T-cell leukemia virus type I infection of monocytes and microglial cells in primary human cultures.

G. Bergey, O. Weislow, F. Ruscetti, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Interferon beta-1b serum levels in multiple sclerosis patients following subcutaneous administration

C. Bever, H. Panitch, O. Khan, 1996, Neurology.

Biomarkers of disease activity in multiple sclerosis

S. Dhib-jalbut, Jerome J. Graber, Suhayl Dhib-Jalbut, 2011, Journal of the Neurological Sciences.

The effects of 4‐aminopyridine in multiple sclerosis patients

C. Bever, H. Panitch, P. A. Anderson, 1994, Neurology.

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010.

M. Sormani, F. Lublin, J. Simon, 2012, International journal of MS care.

Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course

M. Sormani, F. Lublin, J. Simon, 2016 .

Major Histocompatibility Complex Class I Expression on Neurons in Subacute Sclerosing Panencephalitis and Experimental Subacute Measles Encephalitis

T. Yamabe, S. Dhib-jalbut, J. Dymecki, 1996, Journal of neuropathology and experimental neurology.

The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion.

S. Dhib-jalbut, G. Williams, H. Jiang, 1996, Journal of neuroimmunology.

MMP-9 expression is increased in B lymphocytes during multiple sclerosis exacerbation and is regulated by microRNA-320a

K. Balashov, S. Dhib-jalbut, M. Maral Mouradian, 2015, Journal of Neuroimmunology.

Neutralizing antibodies to interferon beta-1a and interferon beta-1b in MS patients are cross-reactive.

O. Khan, S. Dhib-jalbut, S. Dhib-Jalbut, 1998, Neurology.

Recognizing and treating suboptimally controlled multiple sclerosis: steps toward regaining command

M. Freedman, B. Weinstock-Guttman, B. Cohen, 2009, Current medical research and opinion.

Interferon-β-1a induces increases in vascular cell adhesion molecule: implications for its mode of action in multiple sclerosis

P. Calabresi, C. Bever, H. Panitch, 2005, Journal of Neuroimmunology.

A Combination Trial of Estriol Plus Glatimer Acetate in Relapsing-Remitting Multiple Sclerosis (I7-2.002)

R. Elashoff, Angela Bates, N. Sicotte, 2014 .

Immunology of multiple sclerosis.

D. McFarlin, S. Dhib-jalbut, 1990, Annals of allergy.

Different virus antibodies in serum and cerebrospinal fluid of patients suffering from subacute sclerosing panencephalitis

S. Dhib-jalbut, A. Abdelnoor, F. Haddad, 1982, Journal of Neuroimmunology.

Immunocytochemical Binding to Neurons of Serum from Spinocerebellar Degeneration Patients

S. Dhib-jalbut, G. Archer, B. Liwnicz, 1986, Journal of child neurology.

Microglia and necroptosis: The culprits of neuronal cell death in multiple sclerosis.

D. Kalvakolanu, S. Dhib-jalbut, Suhayl Dhib-Jalbut, 2015, Cytokine.

Measles Virus, Neurological Complications of

S. Dhib-jalbut, A. Nizam, 2014 .

Measles Virus, Central Nervous System Complications of

S. Dhib-jalbut, 2003 .

MRI demonstration of gadolinium deposition in bone after monthly triple-dose gadopentetate dimeglumine and correlation with frequency of hypophosphatemia.

R. Munbodh, D. Bageac, L. Wolansky, 2020, Clinical imaging.

Induction of IP-10 chemokine promoter by measles virus: comparison with interferon-γ shows the use of the same response element but with differential DNA–protein binding profiles

M. Shin, P. Vanguri, S. Dhib-jalbut, 1997, Journal of Neuroimmunology.

Bromocriptine treatment of neuroleptic malignant syndrome.

M. Mouradian, S. Dhib-jalbut, E. Means, 1987, The Journal of clinical psychiatry.

Ophthalmoscopic Findings in Subacute Sclerosing Panencephalitis (SSPE): Report of 17 Cases and Review of the Literature

S. Dhib-jalbut, K. Tabbara, F. Haddad, 1983 .

Neutralizing antibodies to interferon β-1a and interferon β-1b in MS patients are cross-reactive

O. Khan, S. Dhib-jalbut, 1998, Neurology.

Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition

S. Yadav, S. Dhib-jalbut, Kouichi Ito, 2021, Journal of clinical medicine.

Immunomodulating functions of recombinant ovine interferon tau: potential for therapy in mulitple sclerosis and autoimmune disorders

O. Khan, P. Subramaniam, S. Dhib-jalbut, 1998, Multiple sclerosis.

This information is current as Sclerosis -1b Therapeutic Effects in Multiple β IFN-Mechanism: Relevance to Peripheral Blood Mononuclear Cells in an -1b Inhibits IL-12 Production in β IFN-

K. Wandinger, S. Dhib-jalbut, Xin Wang, 2017 .